There are also various reports of genetic variations at the FHIT locus and loss of FHIT protein expression in preneoplasias, proposing a tumor-suppressive role for FHIT in the early stages of cancer progression (Waters et al., 2014; Malak et al., 2016; Kiss et al., 2017). This evidence concerns the gene FHIT and neoplasm.